Engineered killer T cell recognizes HIV-1's lethal molecular disguises

November 10, 2008

PHILADELPHIA - Researchers at the University of Pennsylvania School of Medicine and colleagues in the United Kingdom have engineered T cells able to recognize HIV-1 strains that have evaded the immune system. The findings of the study, published online in the journal Nature Medicine, have important implications for developing new treatments for HIV, especially for patients with chronic infection who fail to respond to antiretroviral regimens.

When viruses enter the body, they hijack the machinery of host cells to replicate and spread infection. When the body's cells are infected with a virus they expose small parts of the virus on their surface, offering a molecular fingerprint called an epitope for killer T-cells from the immune system to see. This triggers an immune response, eliminating the virus and any cells involved in its production. However, HIV has the ability to mutate quickly, swiftly disguising its fingerprints to allow it to hide from killer T-cells.

Natural T cells recognize their targets through weak molecular interactions mediated by the T cell receptor. Through a clever molecular process, the investigators were able to isolate a group of T cell receptor encoding genes that bind to HIV-1 about 450-fold more strongly.

"Not only could T cells engineered to express the strongly binding T cell receptor see HIV strains that had escaped detection by natural T cells, but the engineered T cells responded in a much more vigorous fashion so that far fewer T cells were required to control infection," says co-senior author James Riley, PhD, Research Associate Professor of Pathology and Laboratory Medicine at Penn.

What's more, adds first author Angel Varela-Rohena, PhD, who recently completed these studies as part of his PhD dissertation, "With the present availability of potent systems to replicate and deliver high-affinity HIV-1 specific T-cell receptors, billions of these anti-HIV-1 warriors can be generated in two weeks."

"As soon as we saw over a decade ago how quickly the virus can evade the immune system we knew there would never be a conventional vaccine for HIV," explains Professor Andy Sewell from Cardiff University, United Kingdom, co-senior author of the study. "In the face of our engineered assassin cells, the virus will either die or be forced to change its disguises again, weakening itself along the way. We'd prefer the first option but I suspect we'll see the latter."

"We hope to begin clinical trials using the engineered T cells in patients with advanced HIV infection next year, a group for whom many drug regimens have stopped working" says co-author Carl June, MD, Professor of Pathology and Laboratory Medicine and Director of Translational Research at the Abramson Family Cancer Research Institute at Penn. "If the therapy in that group proves successful, we will treat patients with early-stage, well-controlled HIV infection. The goal of these studies is to establish whether the engineered killer T cells are safe, and to identify a range of doses of the cells that can be safely administered."

"We have managed to engineer a receptor that is able to detect HIV's key fingerprints and is able to clear HIV infection in the laboratory," says Bent Jakobsen, PhD, co-lead author and Chief Scientific Officer at Adaptimmune Ltd, the United Kingdom-based company which owns the rights to the technology. "If we can translate those results in the clinic, we could at last have a very powerful therapy on our hands."

University of Pennsylvania School of Medicine

Johns Hopkins HIV Guide 2012
by Joel E. Gallant (Author)

Based On The Same Award-Winning Content As The Johns Hopkins POC-IT Center Online Database, The Johns Hopkins HIV Guide 2012 Is The Most Up-To-Date HIV Treatment And Management Resource On The Market. Written By Dr. Joel E. Gallant, World Renowned Expert In The Field Of HIV And Infectious Disease, This Concise And Well-Organized Medical Reference Is Broken Down Into Several Modules, Including: Diagnosis And Evaluation, Treatment Options, Resistance And Complications, Prophylaxis And Antiretroviral Drug Summaries. Johns Hopkins HIV Guide 2012 Contains The Most Current, Relevant And Evidence-Based Information On HIV And AIDS. Selected Topics Include: • Antiretroviral Therapy Adverse Effects • HIV Antibody Testing • Important Genotype-Resistant Patterns • Musculoskeletal And...

The First Year: HIV: An Essential Guide for the Newly Diagnosed
by Brett Grodeck (Author), M.D. Daniel S. Berger M.D. (Foreword)

This supportive resource explores the next generation of HIV/AIDS drugs and also includes new research on HIV and crystal meth, as well as new insights for the hardest hit population — African Americans.

Living with HIV: A Patient's Guide
by Mark Cichocki (Author)

This helpful guide offers a wealth of information for individuals who have been diagnosed with HIV and for people caring for HIV positive friends and loved ones. It covers the entire HIV lifespan, from prevention to diagnosis and beyond. Valuable tips help the reader make the best decision when choosing a doctor, finding and adhering to the right medication regimen, and, if necessary, making end-of-life plans. All aspects of HIV/AIDS are discussed, including opportunistic and associated infections, dental care, exercise and nutrition, substance use and abuse, and emotional treatment.

MMHIV: Medical Management of HIV Infection (2012 Medical Management of HIV Infection, 16th Edition)
by M.D John G. Bartlett (Author), M.D., M.P.H. Joel E. Gallant (Author), Pharm.D. Paul A. Pham (Author)

MMHIV: The Medical Management of HIV Infection is provided as a resource for physicians and other health care professionals in providing care and treatment to patients with HIV/AIDS. The 2011-2012 edition of Medical Management of HIV Infection reflects substantial changes in the treatment of patients with HIV infection and AIDS since the previous edition was published in 2010. This edition includes 214 tables and more than 900 references to publications or presentations made in 2010 and 2011, reflecting the authors' efforts to keep abreast of new developments by attendance at major scientific conferences and by systematic review of 42 relevant journals. Recommendations presented here are based largely on US federal guidelines for antiretroviral therapy for adults, pregnancy management,...

100 Questions and Answers About HIV and AIDS
by Joel Gallant (Author)

HIV/AIDS: A Very Short Introduction (Very Short Introductions)
by Alan Whiteside (Author)

HIV/AIDS is without doubt the worst epidemic to hit humankind since the Black Death. As of 2004 an estimated 40 million people were living with the disease, and about 20 million had died. Despite rapid scientific advances there is still no cure and the drugs are expensive and toxic. In the developing world, especially in parts of Africa, life expectancy has plummeted to below 35 years, causing a serious decline in economic growth, a sharp increase in orphans, and the imminent collapse of health care systems. The news is not all bleak though. There have been unprecedented breakthroughs in understanding diseases and developing drugs. Because the disease is so closely linked to sexual activity and drug use, the need to understand and change behavior has caused us to reassess what it means...

The Origins of AIDS
by Jacques Pepin (Author)

It is now thirty years since the discovery of AIDS but its origins continue to puzzle doctors and scientists. Inspired by his own experiences working as an infectious diseases physician in Africa, Jacques Pepin looks back to the early twentieth-century events in Africa that triggered the emergence of HIV/AIDS and traces its subsequent development into the most dramatic and destructive epidemic of modern times. He shows how the disease was first transmitted from chimpanzees to man and then how urbanization, prostitution, and large-scale colonial medical campaigns intended to eradicate tropical diseases combined to disastrous effect to fuel the spread of the virus from its origins in Léopoldville to the rest of Africa, the Caribbean and ultimately worldwide. This is an essential new...

Living Hell: The Truth about AIDS and HIV
by Josefina Guardia (Author)

Living Hell presents the uplifting and inspirational stories of some of the AIDS patients with whom author Josefina Guardia worked as a nursing assistant. She opens the door to the reality of AIDS and its victims, as well as that of the families who don't always know how to be supportive in the face of such devastation. She shares in their pain and acknowledges how alone some AIDS patients find themselves during the fight of their lives. This collection of stories recounts their battle to die with dignity-to take their last breaths surrounded by loving kindness. She discusses how some families struggle with the reality of this frightening disease and offers the reminder that, with a little love and understanding, it's possible to make the last days of an AIDS patient less scary....

HIV and the Pathogenesis of AIDS, 3rd Edition
by Jay A. Levy (Author)

The new edition of HIV and the Pathogenesis of AIDS provides a state-of-the-art review of the current research, explains the history of the disease, and examines how scientists, clinicians, and public health workers have responded to the challenges presented by HIV/AIDS in the 25 years since its recognition. Many exciting developments in the field have deepened scientific understanding of HIV/AIDS and have provided novel approaches for prevention and treatment. The book explores potential approaches for therapy and a vaccine for the prevention of HIV infection and AIDS is discussed.

Thoroughly updated and revised, the third edition continues to provide a comprehensive analysis of the subject that is unmatched in the field. Figures and tables illustrate and emphasize key points and...